Insider Trading activities of Millennium Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Millennium Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Millennium Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Millennium Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is MLNM. The reporting company's CIK number is 1002637.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $20,950,401.
The total value of stock option exercises since 2005 is $7,775,462.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Millennium Pharmaceuticals Inc (MLNM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-05 0 $0 2,041 $50,780 0 $0
2008-03 0 $0 74,835 $1,001,078 0 $0
2008-02 0 $0 65,104 $896,446 3,561 $28,933
2008-01 0 $0 49,665 $781,352 3,812 $30,972
2007-12 0 $0 276,487 $4,269,650 334,134 $3,086,139
2007-11 0 $0 112,468 $1,530,344 25,000 $210,250
2007-10 0 $0 96,297 $1,056,216 0 $0
2007-09 0 $0 177,500 $1,838,328 116,505 $892,568
2007-08 0 $0 40,000 $399,150 0 $0
2007-07 0 $0 56,548 $592,897 1,600 $104
2007-06 0 $0 49,500 $512,423 0 $0
2007-05 0 $0 51,929 $569,184 0 $0
2007-04 0 $0 38,500 $446,260 8,500 $58,480
2007-03 0 $0 121,798 $1,321,213 52,071 $393,154
2007-02 0 $0 110,765 $1,246,279 19,787 $166,408
2007-01 0 $0 9,842 $108,458 9,619 $60,983
2006-12 0 $0 0 $0 18,948 $171,054
2006-11 0 $0 35,436 $406,300 20,000 $126,800
2006-10 0 $0 172,500 $2,008,117 112,500 $1,099,462
2006-09 0 $0 10,003 $109,532 0 $0
2006-08 0 $0 177,680 $1,806,394 0 $0
2006-07 0 $0 0 $0 75,000 $295,275
2006-05 0 $0 0 $0 80,000 $384,960
2006-04 0 $0 0 $0 80,000 $384,960
2006-03 0 $0 0 $0 80,000 $384,960

Table 2. Detailed insider stock purchases, sales, and option exercises of Millennium Pharmaceuticals Inc insiders (MLNM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-05-01 Protopapas Anna (Senior Vice President) Sale 2,041 24.88 50,780
2008-03-11 Keating Laurie B. (SVP and General Counsel) Sale 6,784 12.82 86,970
2008-03-11 Fanucci Marsha (SVP, Chief Financial Officer) Sale 4,429 12.82 56,779
2008-03-07 Protopapas Anna (Senior Vice President) Sale 2,010 13.34 26,811
2008-03-07 Dunsire Deborah (President and CEO) Sale 14,096 13.34 188,026
2008-03-07 Keating Laurie B. (SVP and General Counsel) Sale 3,216 13.34 42,898
2008-03-07 Fanucci Marsha (SVP, Chief Financial Officer) Sale 5,989 13.34 79,887
2008-03-06 Simonian Nancy A (Chief Medical Officer) Sale 11,729 13.25 155,409
2008-03-05 Bolen Joseph B (Chief Scientific Officer) Sale 5,606 13.55 75,955
2008-03-05 Smith Peter (Senior Vice President) Sale 5,773 13.55 78,218
2008-03-05 Simonian Nancy A (Chief Medical Officer) Sale 5,813 13.55 78,760
2008-03-03 Simonian Nancy A (Chief Medical Officer) Sale 3,150 13.99 44,068
2008-03-03 Keating Laurie B. (SVP and General Counsel) Sale 6,240 13.99 87,297
2008-02-29 Bolen Joseph B (Chief Scientific Officer) Sale 1,802 13.68 24,642
2008-02-29 Simonian Nancy A (Chief Medical Officer) Sale 1,850 13.68 25,298
2008-02-29 Bianchi Christophe (Executive Vice President) Sale 9,320 13.67 127,432
2008-02-29 Protopapas Anna (Senior Vice President) Sale 4,289 13.67 58,647
2008-02-29 Dunsire Deborah (President and CEO) Sale 23,820 13.67 325,643
2008-02-29 Gansler Stephen M (Senior Vice President) Sale 5,794 13.67 79,221
2008-02-29 Keating Laurie B. (SVP and General Counsel) Sale 4,075 13.67 55,721
2008-02-29 Fanucci Marsha (SVP, Chief Financial Officer) Sale 5,480 13.68 74,939
2008-02-25 Gansler Stephen M (Senior Vice President) Sale 1,650 13.33 21,994
2008-02-19 Protopapas Anna (Senior Vice President) Sale 3,561 14.03 49,960
2008-02-19 Protopapas Anna (Senior Vice President) Option Ex 3,561 8.12 28,933
2008-02-04 Bianchi Christophe (Executive Vice President) Sale 3,463 15.29 52,949
2008-01-18 Protopapas Anna (Senior Vice President) Sale 3,812 16.53 63,012
2008-01-18 Protopapas Anna (Senior Vice President) Option Ex 3,812 8.12 30,972
2008-01-09 Levin Mark J (Director) Sale 10,000 15.12 151,384
2008-01-08 Protopapas Anna (Senior Vice President) Sale 1,071 15.23 16,311
2008-01-08 Gansler Stephen M (Senior Vice President) Sale 1,280 15.23 19,494
2008-01-04 Keating Laurie B. (SVP and General Counsel) Sale 5,281 14.85 78,422
2008-01-03 Protopapas Anna (Senior Vice President) Sale 4,091 16.11 65,906
2008-01-03 Keating Laurie B. (SVP and General Counsel) Sale 4,830 16.11 77,811
2008-01-02 Levin Mark J (Director) Sale 10,000 16.17 161,305
2007-12-26 Levin Mark J (Director) Sale 10,000 15.57 155,720
2007-12-19 Levin Mark J (Director) Sale 10,000 14.95 148,724
2007-12-17 Protopapas Anna (Senior Vice President) Option Ex 143,750 11.51 1,654,562
2007-12-14 Heidrich A Grant Iii (Director) Sale 25,584 15.42 394,633
2007-12-13 Simonian Nancy A (Chief Medical Officer) Sale 113,063 15.44 1,745,127
2007-12-13 Simonian Nancy A (Chief Medical Officer) Option Ex 110,834 7.89 874,147
2007-12-12 Levin Mark J (Director) Sale 10,000 15.65 157,189
2007-12-11 Homcy Charles J (Director) Sale 59,238 15.81 936,434
2007-12-11 Homcy Charles J (Director) Option Ex 59,238 6.49 384,454
2007-12-06 Bolen Joseph B (Chief Scientific Officer) Sale 20,312 15.18 308,336
2007-12-06 Bolen Joseph B (Chief Scientific Officer) Option Ex 20,312 8.52 172,976
2007-12-06 Keating Laurie B. (SVP and General Counsel) Sale 1,716 15.18 26,048
2007-12-05 Levin Mark J (Director) Sale 10,000 15.22 151,918
2007-12-03 Protopapas Anna (Senior Vice President) Sale 5,674 14.55 82,556
2007-11-28 Levin Mark J (Director) Sale 10,000 15.23 152,310
2007-11-26 Protopapas Anna (Senior Vice President) Sale 5,000 14.32 71,600
2007-11-21 Levin Mark J (Director) Sale 10,000 14.12 140,972
2007-11-19 Protopapas Anna (Senior Vice President) Sale 5,000 13.62 68,100
2007-11-14 Levin Mark J (Director) Sale 10,000 13.96 139,348
2007-11-12 Protopapas Anna (Senior Vice President) Sale 5,000 13.41 67,050
2007-11-07 Levin Mark J (Director) Sale 10,000 13.13 131,596
2007-11-05 Protopapas Anna (Senior Vice President) Sale 5,000 12.62 63,099
2007-11-05 Keating Laurie B. (SVP and General Counsel) Sale 25,000 12.68 316,875
2007-11-05 Keating Laurie B. (SVP and General Counsel) Option Ex 25,000 8.41 210,250
2007-11-01 Protopapas Anna (Senior Vice President) Sale 368 12.00 4,416
2007-10-10 Bolen Joseph B (Chief Scientific Officer) Sale 11,297 11.00 124,267
2007-10-10 Kucherlapati Raju S (Director) Sale 75,000 11.06 829,500
2007-10-03 Levin Mark J (Director) Sale 10,000 10.24 102,449
2007-09-26 Levin Mark J (Director) Sale 10,000 10.14 101,420
2007-09-19 Fanucci Marsha (SVP, Chief Financial Officer) Sale 7,436 10.67 79,342
2007-09-19 Homcy Charles J (Director) Sale 40,000 10.68 427,200
2007-09-19 Levin Mark J (Director) Sale 10,000 10.56 105,570
2007-09-18 Fanucci Marsha (SVP, Chief Financial Officer) Sale 10,064 10.58 106,477
2007-09-18 Homcy Charles J (Director) Sale 40,000 10.33 413,240
2007-09-18 Homcy Charles J (Director) Option Ex 60,831 8.44 513,413
2007-09-17 Protopapas Anna (Senior Vice President) Option Ex 25,674 4.91 125,956
2007-09-17 Homcy Charles J (Director) Sale 10,000 9.76 97,630
2007-09-12 Levin Mark J (Director) Sale 10,000 10.00 99,960
2007-09-05 Homcy Charles J (Director) Option Ex 30,000 8.44 253,199
2007-09-05 Levin Mark J (Director) Sale 10,000 10.15 101,489
2007-09-04 Homcy Charles J (Director) Sale 30,000 10.20 306,000
2007-08-29 Levin Mark J (Director) Sale 10,000 9.77 97,710
2007-08-22 Levin Mark J (Director) Sale 10,000 9.83 98,260
2007-08-15 Levin Mark J (Director) Sale 10,000 10.23 102,280
2007-08-01 Levin Mark J (Director) Sale 10,000 10.09 100,900
2007-07-31 Heidrich A Grant Iii (Director) Sale 1,600 10.12 16,191
2007-07-31 Heidrich A Grant Iii (Director) Option Ex 1,600 .06 104
2007-07-30 Smith Peter (Senior Vice President) Sale 11,284 10.11 114,081
2007-07-19 Dunsire Deborah (President and CEO) Sale 33,664 10.61 357,175
2007-07-11 Levin Mark J (Director) Sale 10,000 10.54 105,450
2007-06-27 Levin Mark J (Director) Sale 10,000 10.33 102,673
2007-06-20 Levin Mark J (Director) Sale 10,000 10.44 104,400
2007-06-13 Levin Mark J (Director) Sale 10,000 10.33 103,260
2007-06-06 Levin Mark J (Director) Sale 10,000 10.46 104,620
2007-05-30 Levin Mark J (Director) Sale 10,000 10.75 107,500
2007-05-23 Levin Mark J (Director) Sale 10,000 10.84 108,440
2007-05-16 Levin Mark J (Director) Sale 10,000 10.93 109,300
2007-05-09 Levin Mark J (Director) Sale 10,000 11.11 111,060
2007-05-02 Levin Mark J (Director) Sale 10,000 11.15 111,530
2007-05-01 Protopapas Anna (Senior Vice President) Sale 1,929 11.07 21,354
2007-04-18 Levin Mark J (Director) Sale 10,000 12.00 119,990
2007-04-11 Levin Mark J (Director) Sale 10,000 11.45 114,500
2007-04-09 Protopapas Anna (Senior Vice President) Sale 4,250 11.56 49,130
2007-04-09 Protopapas Anna (Senior Vice President) Option Ex 4,250 6.88 29,240
2007-04-04 Levin Mark J (Director) Sale 10,000 11.42 114,190
2007-04-02 Protopapas Anna (Senior Vice President) Sale 4,250 11.40 48,450
2007-04-02 Protopapas Anna (Senior Vice President) Option Ex 4,250 6.88 29,240
2007-03-28 Levin Mark J (Director) Sale 10,000 11.33 113,300
2007-03-26 Protopapas Anna (Senior Vice President) Sale 8,500 11.38 96,730
2007-03-26 Protopapas Anna (Senior Vice President) Option Ex 8,500 6.88 58,480
2007-03-21 Levin Mark J (Director) Sale 10,000 10.92 109,170
2007-03-20 Keating Laurie B. (SVP and General Counsel) Sale 12,400 11.00 136,400
2007-03-20 Keating Laurie B. (SVP and General Counsel) Option Ex 12,400 8.41 104,284
2007-03-19 Protopapas Anna (Senior Vice President) Sale 4,088 10.73 43,864
2007-03-19 Protopapas Anna (Senior Vice President) Option Ex 4,088 7.99 32,663
2007-03-14 Levin Mark J (Director) Sale 10,000 10.68 106,750
2007-03-13 Keating Laurie B. (SVP and General Counsel) Sale 25,568 10.92 279,100
2007-03-13 Keating Laurie B. (SVP and General Counsel) Option Ex 19,000 8.41 159,790
2007-03-12 Protopapas Anna (Senior Vice President) Sale 1,970 10.64 20,960
2007-03-12 Fanucci Marsha (SVP, Chief Financial Officer) Sale 4,245 10.64 45,166
2007-03-09 Protopapas Anna (Senior Vice President) Sale 3,833 10.58 40,572
2007-03-09 Protopapas Anna (Senior Vice President) Option Ex 3,833 2.27 8,697
2007-03-08 Dunsire Deborah (President and CEO) Sale 10,771 10.41 112,126
2007-03-08 Fanucci Marsha (SVP, Chief Financial Officer) Sale 6,173 10.41 64,260
2007-03-07 Levin Mark J (Director) Sale 10,000 10.44 104,450
2007-02-21 Levin Mark J (Director) Sale 10,000 11.14 111,359
2007-02-16 Homcy Charles J (Director) Sale 27,774 11.24 312,179
2007-02-14 Levin Mark J (Director) Sale 10,000 11.13 111,340
2007-02-12 Keating Laurie B. (SVP and General Counsel) Sale 29,469 11.29 332,616
2007-02-12 Keating Laurie B. (SVP and General Counsel) Option Ex 19,787 8.41 166,408
2007-02-12 Tepper Robert I (President, R&D) Sale 22,500 11.36 255,600
2007-02-06 Fanucci Marsha (SVP, Chief Financial Officer) Sale 7,497 11.17 83,741
2007-02-02 Bianchi Christophe (Executive Vice President) Sale 3,525 11.19 39,444
2007-01-24 Homcy Charles J (Director) Option Ex 2,394 6.34 15,177
2007-01-23 Homcy Charles J (Director) Option Ex 7,225 6.34 45,806
2007-01-04 Protopapas Anna (Senior Vice President) Sale 4,524 11.02 49,854
2007-01-04 Keating Laurie B. (SVP and General Counsel) Sale 5,318 11.02 58,604
2006-12-14 Wild Anthony H (Director) Option Ex 8,948 9.67 86,554
2006-12-04 Friel Robert F (Director) Option Ex 10,000 8.45 84,500
2006-11-21 Homcy Charles J (Director) Sale 20,000 11.44 228,800
2006-11-21 Homcy Charles J (Director) Option Ex 20,000 6.34 126,800
2006-11-20 Tepper Robert I (President, R&D) Sale 15,000 11.50 172,425
2006-11-01 Protopapas Anna (Senior Vice President) Sale 436 11.64 5,075
2006-10-30 Tepper Robert I (President, R&D) Sale 60,000 11.88 712,680
2006-10-27 Dunsire Deborah (President and CEO) Sale 112,500 11.52 1,295,437
2006-10-27 Dunsire Deborah (President and CEO) Option Ex 112,500 9.77 1,099,462
2006-09-18 Fanucci Marsha (SVP, Chief Financial Officer) Sale 10,003 10.95 109,532
2006-08-17 Heidrich A Grant Iii (Director) Sale 95,980 10.42 1,000,015
2006-08-14 Heidrich A Grant Iii (Director) Sale 71,300 9.87 703,731
2006-08-10 Heidrich A Grant Iii (Director) Sale 7,000 9.87 69,090
2006-08-09 Tepper Robert I (President, R&D) Sale 1,700 9.87 16,779
2006-08-09 Heidrich A Grant Iii (Director) Sale 1,700 9.87 16,779
2006-07-31 Tepper Robert I (President, R&D) Option Ex 75,000 3.94 295,275
2006-05-02 Lander Eric S (Director) Option Ex 80,000 4.81 384,960
2006-04-24 Heidrich A Grant Iii (Director) Option Ex 80,000 4.81 384,960
2006-03-20 Kucherlapati Raju S (Director) Option Ex 80,000 4.81 384,960

Insider trading activities including stock purchases, stock sales, and option exercises of MLNM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Millennium Pharmaceuticals Inc (symbol MLNM, CIK number 1002637) see the Securities and Exchange Commission (SEC) website.